1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Success Case Study: Manflu Men's Cold and Flu Remedies ; Increasing differentiation in OTC through demographic targeting

Summary
The OTC healthcare category is expected to see a compound annual growth rate of -1.19% in the UK between 2014 and 2019. This could be due to consumers wanting to know and understand what they eat and drink, leading them to seek out more "natural" health solutions and take less of a pharma-driven approach, including for the provision of vitamins and minerals.

Key Findings
- "Success Case Study: Manflu Men's Cold and Flu Remedies" highlights how a more "natural" approach for OTC medicines is the way forward for many "ingredient-aware" consumers who are also time-poor.

- This new lifestyle attribute is changing what consumers look for in an OTC product. The focus is now moving not only towards more drug-free products, but also towards something that can help prevent illnesses rather than curing them.

- A company must have an in-depth understanding of its target audience as well as its own products, especially in a confusing category such as cold and flu remedies. It is important to think about what the brand stands for and where it fits in the current market.


Synopsis
This case study is part of Canadean's Successes and Failures research. It examines the details of and reasons behind the success of Manflu Men's Cold and Flu Remedies.It delivers the critical "what?", "why?", and "so what?" analysis to teach you crucial lessons that increase your chances of launching successful products.


Reasons To Buy
- Reduce the risk of failure by learning from brands/products that have under-performed: failed innovation can severely impact profit and reputation.

- Understand the relevant consumer trends and attitudes that drive and support innovation success so you can tap into what is really impacting the industry.

- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.

- Access valuable strategic take-outs to help direct future decision-making and inform new product development.

Table Of Contents

Success Case Study: Manflu Men's Cold and Flu Remedies ; Increasing differentiation in OTC through demographic targeting

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

OTC

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.